Peptide profile · Immune
Thymulin (FTS)
Zinc-dependent thymic hormone for immune restoration and T cell maturation
Molecular formula
C33H54N12O15
- CAS number
- 63958-90-7
- PubChem
- 71300623
- Developed · 1977
- Jean-François Bach, INSERM / Hôpital Necker, Paris, France
Amino acid sequence
pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn1 – 2mg
Every documented dose level
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| Days 10-20 | 1-2 mg | Once daily (often dosed in the evening) | Subcutaneous injection |
| Several weeks | 100-400 mcg | Three times weekly | Intradermal injection |
Best for immune system restoration & t cell maturation in immunocompromised states
Best for
Consider alternatives if
Do not use if
- You have thymic malignancy or tumor
- You have uncontrolled autoimmune disease
- You are allergic to any peptide or component
- You are pregnant or breastfeeding
Use with caution if
- You have active autoimmune disease (medical supervision essential)
- You have zinc deficiency (supplement concurrently)
- You have recent acute infection (may need to delay until recovery)
- You are taking immunosuppressive medications
Not sure?
Compare Thymulin (FTS) with similar peptides to find the best fit for your goals.
Route
Subcutaneous injection
Best sites
- Abdomen (avoid 2 inches around navel)
- Upper arm/deltoid region (outer surface)
- Thigh (outer front or outer side)
- Lower back above buttocks
The Thymulin (FTS) injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.
3 common side effects · 3 serious
Thymulin is a naturally occurring thymic hormone with favorable safety profile in research.
No reported serious adverse events in animal models even at high doses. Limited human safety data but observed studies suggest good tolerability. Requires concurrent zinc supplementation for biological activity and additional safety assurance.
Most concerns relate to immune overactivation in susceptible individuals, not direct peptide toxicity.
Safety data derives primarily from animal models and in vitro human studies. Direct human clinical trials are limited. Long-term safety profile in healthy volunteers not extensively documented. Use should be considered research-level, not FDA-approved therapeutic.
Common side effects · experienced by some users
Local injection site reactions
Mild redness, swelling, or itching at injection site lasting 1-2 hours post-injection
Management
Rotate injection sites daily, apply ice if swelling persists, use smaller gauge needle (31G recommended)
Mild fatigue or lethargy
Temporary fatigue during first 1-2 weeks as immune system begins mobilization; may feel 'immune activation response'
Management
Ensure adequate sleep (8+ hours), stay hydrated, continue standard activity unless severe, usually resolves by week 2-3
Transient headache
Mild to moderate headache, usually occurring within hours of injection, lasting 2-8 hours
Management
Take acetaminophen or ibuprofen if needed, ensure hydration, rest in quiet environment, may decrease with subsequent doses
Serious side effects
Severe allergic reaction
Rare but possible anaphylaxis or severe hypersensitivity response to peptide or reconstitution components
Management
Stop use immediately, seek emergency medical care, keep epinephrine auto-injector available, inform provider of peptide use
Uncontrolled immune activation
Excessive pro-inflammatory cytokine release in susceptible individuals, potentially mimicking cytokine storm (theoretical risk)
Management
Reduce dose immediately, consult physician, consider temporary discontinuation, monitor inflammatory markers
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe allergic reactions or anaphylaxis
- Persistent fever above 101.5°F lasting more than 24 hours
- Severe joint or muscle pain unrelated to injection site
- Signs of autoimmune activation (rashes, persistent inflammation)
- Severe headaches or neurological symptoms
- Uncontrolled immune activation with systemic symptoms
- Pregnant status or planning pregnancy
- Development of new autoimmune disease symptoms
This information is for research purposes only. Stopping thymulin or any peptide should be discussed with a qualified healthcare provider. Do not discontinue abruptly without medical guidance. If experiencing emergency symptoms, seek immediate medical attention.
With other peptides
- Thymosin Alpha 1: may have additive immune effects; combining not well-studied
- BPC-157: complementary anti-inflammatory effects; safe to combine with monitoring
- Semorelin: indirect interaction through growth hormone effects on immune restoration; generally compatible
With medications
- Corticosteroids (high-dose): may antagonize thymulin effects; use with caution and medical oversight
- Immunosuppressants: direct antagonism; avoid combination without physician guidance
- NSAIDs: may reduce anti-inflammatory signaling; consider alternatives
- Antibiotics: generally safe; no direct interactions expected
With supplements
- Zinc (15-30 mg daily): ESSENTIAL - thymulin requires zinc for biological activity; combine daily
- Vitamin D (1000-2000 IU daily): synergistic immune benefits; safe to combine
- Vitamin C (500-1000 mg daily): antioxidant support; safe to combine
- Iron supplements: may compete with zinc absorption; separate by 2+ hours if possible
- Calcium supplements: may reduce zinc absorption; separate by 2+ hours
Limited human trials · first signs week 1-2
Evidence level
Limited human trials
60/100
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
Thymulin is a small hormone (nonapeptide) naturally made by your thymus gland, which is like your immune system's training center.
It's the boss that tells immune cells how to develop properly and when to calm down inflammation. The catch: thymulin NEEDS zinc to work. Without zinc, it's like having the instruction manual but no batteries.
As you age, your thymulin levels drop, which is why older people get sick more often. This peptide restores thymulin activity and helps your immune system remember how to fight infections and balance inflammation.
The deeper mechanism
Thymulin (Zn-FTS) is a nine-amino acid peptide (pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic reticulo-epithelial cells that acts as a thymic hormone essential for T lymphocyte differentiation and maturation.
The zinc cofactor (Zn2+) is structurally integrated into thymulin's active site, essential for three-dimensional conformation and receptor binding.
Mechanisms: (1) T Cell Maturation - Thymulin promotes transition of immature thymocytes to mature T cells by signaling through specific cell surface receptors, increasing both CD4+ helper T cells and CD8+ suppressor/cytotoxic T cells; (2) Anti-inflammatory Signaling - Thymulin inhibits NF-κB transcription factor activation, suppresses pro-inflammatory cytokine production (IL-6, TNF-α, IL-8), and suppresses p38 MAPK phosphorylation; (3) Immune Homeostasis - Thymulin maintains proper helper/suppressor T cell balance; dysregulation of this balance contributes to immunodeficiency and autoimmunity; (4) Neuroprotection - CNS microglia respond to thymulin signaling, reducing endotoxin-induced neuroinflammation through NF-κB inhibition; (5) Aging - Thymulin levels decline with age (~50% reduction by age 60), contributing to immune senescence; restoration of thymulin can reverse age-related thymic involution.
Zinc deficiency reduces active thymulin bioavailability even if thymus production is normal, making zinc co-supplementation critical for efficacy.
What to expect
Week 1-2
What you might notice
- Mild fatigue or 'immune activation' sensation
- Possible transient headache or mild fever
- Local injection site reactions (redness, swelling)
- Sleep may feel deeper or dreams more vivid
What's normal
- Mild systemic symptoms indicating immune mobilization
- Local injection reactions lasting 1-2 hours
- Temporary appetite changes
- Slight elevation in body temperature
What's next
- Continue current dose through week 2 to allow adaptation
- Monitor for resolution of acute symptoms
- Ensure zinc supplementation compliance (essential for activity)
- Begin checking baseline immune markers if available
Week 2-4
What you might notice
- Most acute symptoms resolve or significantly diminish
- Improved energy levels and mental clarity
- Reduced susceptibility to minor infections
- Better wound healing and skin health
- Improved sleep quality
What's normal
- Continued minor injection site reactions (should be less pronounced)
- Occasional transient headache
- Lymph node palpability may persist (normal immune activation)
- Gradual improvement in baseline immune function
What's next
- Consider dose adjustment based on tolerance and immune response
- Schedule immune function testing if available (T cell counts, cytokine panels)
- Maintain zinc supplementation consistently
- Evaluate effectiveness against baseline goals
Week 4-6
What you might notice
- Measurable improvement in immune function markers
- Significant reduction in infection frequency
- Enhanced recovery from illness or injury
- Improved inflammatory pain reduction (if high doses used)
- Sustained energy improvement and immune resilience
What's normal
- Minimal to no injection site reactions
- Complete resolution of systemic symptoms
- Persistent mild lymph node changes (can take weeks to normalize)
- Stabilization at new immune homeostasis level
What's next
- Complete final immune function testing
- Evaluate goal achievement
- Decide on continuation vs. cycling of thymulin
- Consider maintenance dosing or discontinuation based on response
Signs it's working
Immune Function Markers
- Increased CD4+ T cell count (absolute number increase of 200-500 cells/mm³)
- Improved CD4+/CD8+ ratio toward healthy range
- Reduced pro-inflammatory cytokines (IL-6, TNF-α, IL-8 decrease 20-50%)
- Improved delayed-type hypersensitivity skin testing response
- Increased thymic output markers (increased TREC counts)
Signs it's working
Clinical Outcomes
- Reduced frequency of infections (fewer colds, respiratory infections, etc.)
- Faster recovery from illness when infections occur
- Improved vaccine response (better antibody titers)
- Enhanced wound healing and recovery from injury
- Reduced frequency or severity of inflammatory symptoms
Signs it's working
Subjective Health Markers
- Sustained improved energy and reduced fatigue
- Better immune resilience (feeling 'less prone to getting sick')
- Improved sleep quality and immune consolidation
- Reduced chronic inflammation symptoms
- Improved recovery from physical exertion
Not seeing results?
Common reasons
- Inadequate zinc co-supplementation (thymulin requires zinc for biological activity; verify taking 15-30 mg daily)
- Dose too low for individual immune status (may need adjustment upward after 2 weeks)
- Reconstitution errors or improper storage (degradation reduces peptide activity)
- Injection technique issues affecting bioavailability (ensure proper subcutaneous placement, not intramuscular or intradermal)
- Short timeframe for assessment (immune restoration takes 3-4 weeks minimum; 6 weeks typical)
- Underlying severe zinc deficiency or malabsorption preventing thymulin activation even with supplementation
Why is zinc so important with thymulin?
Zinc is not optional—it's structurally part of thymulin's active form (Zn-FTS). Without adequate zinc, thymulin cannot bind to its receptors or exert any biological effect. This is why the research designation is 'Zn-FTS' (zinc-FTS). If you're deficient in zinc, thymulin supplementation alone won't work. You must take 15-30 mg elemental zinc daily. Zinc deficiency is also common in aging populations and malnutrition —exactly the groups that might benefit from thymulin.
What's the difference between thymulin and PAT (its analogue)?
PAT is a synthetic analogue of thymulin that's designed to be more stable and potentially more potent. In research, PAT showed equal or stronger analgesic and anti-inflammatory effects than native thymulin at much lower concentrations. PAT may also have better shelf-life and stability. However, PAT has less clinical evidence than thymulin itself. If you can access PAT-based formulations, they may be preferable, but thymulin remains the most researched form.
How do I know if thymulin is working?
The best measure is immune function testing: CD4+ T cell count, CD4+/CD8+ ratio, and pro-inflammatory cytokine levels (IL-6, TNF-α). These should show improvement by week 4-6. Clinically, you'll notice fewer infections, faster recovery from illness, better vaccine responses, and improved energy. If you don't have access to immune testing, track infection frequency, wound healing, and energy levels over 6 weeks.
Can thymulin cause immune overactivation or autoimmunity?
Theoretically, yes—excessive immune activation could trigger or worsen autoimmune disease in susceptible individuals. This is why thymulin use requires caution in people with existing autoimmune conditions and why medical supervision is recommended. In research, no severe autoimmune reactions have been documented, but the risk exists. Start low, dose slowly, monitor closely, and stop if you notice signs of autoimmune flare (new rashes, persistent inflammation, joint pain).
How long do I use thymulin, and can I cycle it?
Most research protocols use 4-6 week cycles. You could potentially cycle thymulin (e.g., 6 weeks on, 2-4 weeks off) to avoid tolerance or give your immune system recovery time. However, optimal cycling schedules haven't been formally studied. Some people use thymulin as a short-term immune restoration tool (one 4-6 week cycle) during aging or recovery from malnutrition. Consult with a healthcare provider about your specific situation.
Is thymulin FDA approved?
No. Thymulin is a research compound without FDA approval in the United States. It exists in a gray zone: there are no direct clinical trials of native thymulin on ClinicalTrials.gov, only observational studies and extensive animal research. This means efficacy claims are based on preclinical data and in vitro human studies, not large-scale human trials. Use should be considered experimental and research-level.
Can I inject thymulin while taking immunosuppressive medications?
Not without medical supervision. Thymulin is an immune activator, and immunosuppressive medications are designed to suppress the immune system. They work in opposite directions. If you're on immunosuppressants (for autoimmune disease, organ transplant, etc.), talk to your doctor before using thymulin. In some cases, low-dose thymulin under medical supervision might be possible, but it requires careful monitoring.
What happens if I stop thymulin suddenly?
There's no withdrawal effect or rebound, but you'll lose the immune-boosting benefits over time. Thymulin has a short half-life (2 hours), so it clears quickly. If you were benefiting from immune restoration, stopping means those benefits fade. Whether to stop or cycle depends on your goals and immune status. Consult your healthcare provider before stopping.
Can I combine thymulin with other peptides like BPC-157 or Thymosin Alpha 1?
Possibly, but this combination hasn't been well-studied. BPC-157 has complementary anti-inflammatory effects, so theoretically combining them makes sense. Thymosin Alpha 1 has similar immune-boosting properties, so combining might cause 'overdose' effects. If you're interested in combining peptides, do so under medical supervision and start with lower doses of each to assess tolerance and monitor immune markers closely.
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Thymulin (FTS), on one page.
Thymulin (FTS) dosing protocol